HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Industrial Cannabis/Industrial Hemp

449.472

-12.956-2.80%

Number of Gainers:1

Number of Losers:5

Number of Flat:1

PE:- -

High:464.110

Open:462.188

Low:448.865

Close:462.428

Volume:46.14M

Turnover:39.55M

Market Cap:18.42B

Float Cap:18.42B

Loading ...

Meilleure Health (SEHK:2327) Stock Price Lags Fresh Profit Surge

Simply Wall St.

LifeTech Swings to FY26 H1 Net Loss of RMB 34.3 Million; Revenue Falls 11.2% to RMB 600.8 Million

Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches

Simply Wall St.

Meilleure Health International Reports 87% Surge in Interim Profit to HK$28.34 Million

Hong Kong's Meilleure Health H1 Revenue Surges on Property Sales, but Margins Hit

Meilleure Health Declares Interim Dividend of HKD 0.0015 a Share

Meilleure Health FY26 H1 Profit Rises 87.4% to HK$ 28.33 Million; Revenue Climbs 840.6% to HK$ 164.57 Million

Meilleure Health International Industry Group Declared an Interim Dividend of Hk0.15 Cents Per Share

THOMSON REUTERS

Meilleure Health International Industry Group H1 Net Income Attributable HKD 28.3 Million

THOMSON REUTERS

Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion

Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List

SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Sihuan Pharmaceutical Holdings Group H1 Net Income Attributable RMB 224.7 Million

THOMSON REUTERS

Sihuan Pharma Appoints Song Xiaomi as CFO

Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026

THOMSON REUTERS

Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK1600/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1600","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","market":"HK","secType":"PLATE","nameCN":"Industrial Cannabis/Industrial Hemp","latestPrice":449.47214,"timestamp":1787904511585,"preClose":462.42813,"halted":0,"volume":46136000,"delay":0,"changeRate":-0.028017,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-12.955994,"latestTime":"08-28 16:00:00","open":462.1883,"high":464.11035,"low":448.86462,"amount":39553647,"amplitude":0.032969,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"pbRate":1.295833,"peRate":28.118322,"turnoverRate":0.001497,"increases":1,"decrements":5,"flats":1,"marketCap":18421986592,"floatMarketCap":18421986592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","high":464.11035,"amplitude":0.032969,"preClose":462.42813,"low":448.86462,"pbRate":"1.295833","latestPrice":449.47214,"volume":46136000,"delay":0,"open":462.1883,"prevYearClose":572.4504,"prevWeekClose":475.684,"prevMonthClose":486.869,"prevQuarterClose":454.412,"fiveDayClose":475.684,"twentyDayClose":486.869,"sixtyDayClose":502.169,"secType":"PLATE","market":"HK","turnoverRate":0.001497,"peRate":28.118322,"marketCap":18421986592,"floatMarketCap":18421986592,"timestamp":1787904511585,"nameCN":"Industrial Cannabis/Industrial Hemp"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1600\",,,,undefined,":{"bkCode":"BK1600","up":1,"down":5,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1600\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662093518","title":"Meilleure Health (SEHK:2327) Stock Price Lags Fresh Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093518","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093518?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:31","pubTimestamp":1787920272,"startTime":"0","endTime":"0","summary":"Meilleure Health International Industry Group stock closed at HK$0.24, with recent returns over the past week and month slightly in the red and the 90 day move deeper in decline. Yet H1 2026 earnings landed with a headline that is hard to ignore. Revenue for the period came in at HK$164.57m and net income reached HK$28.34m, which feeds into a trailing 12 month profit profile that investors may wish to weigh carefully in light of the recent share price weakness.\nLove the fresh profit profile...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3081000-choice2-main-header/1585186749644","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3081000-choice2-main-header/1585186749644"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/capital-goods/hkg-2327/meilleure-health-international-industry-group-shares/news/meilleure-health-sehk2327-stock-price-lags-fresh-profit-surg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/capital-goods/hkg-2327/meilleure-health-international-industry-group-shares/news/meilleure-health-sehk2327-stock-price-lags-fresh-profit-surg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1124","02327","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055928","title":"LifeTech Swings to FY26 H1 Net Loss of RMB 34.3 Million; Revenue Falls 11.2% to RMB 600.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055928","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055928?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:20","pubTimestamp":1787890843,"startTime":"0","endTime":"0","summary":"LifeTech swings to FY26 H1 net loss of RMB 34.3 million; revenue falls 11.2% to RMB 600.8 millionLifeTech Scientific posted a net loss attributable to owners of RMB 34.3 million, swinging from profit;","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLdQ5JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","01302","BK1583","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084715","title":"Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084715","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084715?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:24","pubTimestamp":1787840647,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group entered these results following a period of weak share price performance, with the stock down over the past week, month and quarter, yet trading on a rich P/E of 21x. That is a set up for emotional trading. The headline from this half year is simple. Profitability has firmed up, with basic earnings per share at C¥0.0249 on revenue of C¥1,161.2m. The tug of war now is between investors who are concerned about the valuation strain and those who see a company...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/sihuan-pharmaceutical-sehk460-stock-price-lags-profit-recove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/sihuan-pharmaceutical-sehk460-stock-price-lags-profit-recove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK1600","BK1593","00460","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173617335","title":"Meilleure Health International Reports 87% Surge in Interim Profit to HK$28.34 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1173617335","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173617335?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:47","pubTimestamp":1787827638,"startTime":"0","endTime":"0","summary":"Meilleure Health International (02327) has announced its interim results for 2026, posting a revenue of approximately HK$165 million, marking a substantial year-on-year increase of about 840.6%.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02327","BK1124","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706948","title":"Hong Kong's Meilleure Health H1 Revenue Surges on Property Sales, but Margins Hit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706948","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706948?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:44","pubTimestamp":1787827454,"startTime":"0","endTime":"0","summary":"Hong Kong's Meilleure Health H1 revenue surges on property sales, but margins hitOverviewHong Kong healthcare and property group's H1 revenue rose 841% yr/yr, driven by property salesGross profit marg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1124","BK1188","00373","02327"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662632706","title":"Meilleure Health Declares Interim Dividend of HKD 0.0015 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662632706","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662632706?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:43","pubTimestamp":1787827424,"startTime":"0","endTime":"0","summary":"Meilleure Health declares interim dividend of HKD 0.0015 a shareMeilleure Health declared an interim dividend of HKD 0.0015 per share for the six months ended June 30, 2026.Shares trade ex-dividend on Sept. 9.Holders on record as of Sept. 16 will be entitled to the payout.Payment is scheduled for Sept. 30.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Meilleure Health International Industry Group Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on August 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL20r5PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1124","BK1600","02327"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050827","title":"Meilleure Health FY26 H1 Profit Rises 87.4% to HK$ 28.33 Million; Revenue Climbs 840.6% to HK$ 164.57 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050827","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662050827?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:35","pubTimestamp":1787826924,"startTime":"0","endTime":"0","summary":"Meilleure Health FY26 H1 profit rises 87.4% to HK$ 28.33 million; revenue climbs 840.6% to HK$ 164.57 millionMeilleure Health posted profit attributable to owners of HK$28.34 million, up 87.4%, with E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL6srS50:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1124","02327","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705708","title":"Meilleure Health International Industry Group Declared an Interim Dividend of Hk0.15 Cents Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705708","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705708?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXGKTSGX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","02327","BK1124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270548","title":"Meilleure Health International Industry Group H1 Net Income Attributable HKD 28.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270548?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXGKTSGX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02327","BK1124","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705289","title":"Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705289","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705289?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826855,"startTime":"0","endTime":"0","summary":"Sihuan Pharma files HKEX next-day return disclosing share repurchase at HKD 0.81Sihuan Pharmaceutical repurchased 10,000,000 ordinary shares on Aug. 27, holding all as treasury shares.Buyback price ra","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL6cXYkS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","00460","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662717592","title":"Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717592","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662717592?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:54","pubTimestamp":1787752465,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical H1 revenue rises on nuclear medicine demandOverviewHong Kong-listed pharma group's H1 revenue rose 3.2% yr/yr to HK$6.39 blnNet income attributable to owners fell to HK$1.06 bln f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","BK1593","BK1589","BK1515","00512","BK1600","03692","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715194","title":"China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715194","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715194?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:36","pubTimestamp":1787744170,"startTime":"0","endTime":"0","summary":"China's Zhongzhi Pharmaceutical H1 revenue falls 10%OverviewChina pharmaceutical maker's half-year revenue fell 10.3% yr/yrProfit attributable to owners rose 3.8% yr/yrGross profit and margin declined","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","BK1600","BK1606","03692","BK1515","BK1593","BK1191","03737","00460","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973617","title":"Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973617","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662973617?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:08","pubTimestamp":1787738933,"startTime":"0","endTime":"0","summary":"Sihuan Pharma FY26 H1 profit attributable to owners rises 119% to RMB 224.7 million; revenue increases 1.3% to RMB 1.16 billionSihuan Pharmaceutical posted profit attributable to owners of RMB 224.7 m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLc1wDYT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1600","BK1191","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662794653","title":"Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List","url":"https://stock-news.laohu8.com/highlight/detail?id=2662794653","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662794653?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:38","pubTimestamp":1787737093,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical files board, committee roles and disclosure-responsible management listSihuan Pharmaceutical named Che Fengsheng as chairman; Guo Weicheng as vice chairman, chief executive; exec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1yGHl8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1600","BK1191","BK1515","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191993997","title":"SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1191993997","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191993997?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:36","pubTimestamp":1787718981,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has reported its interim results for the six months ended June 30, 2026, showcasing a substantial jump in profitability. The group recorded a total revenue of RMB 1.161 billion,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","159992","IBBQ","BK1574","BK1600","BK1161","06978","BK1515","MEDX","LNGR","BK1593","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662176420","title":"Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662176420","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662176420?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:15","pubTimestamp":1787717732,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strengthOverviewChina pharmaceutical group's interim revenue rose 1.3% yr/yr, led by medical aesthetics growthNet income attributable t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N039:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","LU1969619763.USD","HK0000165453.HKD","LU1328277881.USD","LU0455707207.USD","LU0501845795.SGD","LU2242644610.SGD","BK1600","LU2097828474.EUR","LU1960683339.HKD","SG9999004220.SGD","LU1813983027.USD","688428","KURE","LU2097828714.EUR","01801","LU1152091754.HKD","LU0463099449.HKD","LU2039709279.SGD","LU2097828805.USD","LU1008478684.HKD","LU2097828631.EUR","BK0239","IE0008369823.USD","LU0502904849.HKD","LU2328871848.SGD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1152091168.USD","BK1191","LU1226287529.USD","LU0314109678.HKD","LU0244354667.USD","LU2488822045.USD","LU0140636845.USD","00460","BK1583","IE00B031HY20.USD","IE00B543WZ88.USD","BK1589","LU0067412154.USD","LU1188198961.HKD","LU1226288253.USD","BK1161","BK1593","01093","IE00BZ08YS42.EUR","LU1226288170.HKD","LU0880133367.SGD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662641907","title":"Sihuan Pharmaceutical Holdings Group H1 Net Income Attributable RMB 224.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662641907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662641907?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:04","pubTimestamp":1787717060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nPLXL73S0P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1593","BK1600","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776415","title":"Sihuan Pharma Appoints Song Xiaomi as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776415","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662776415?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:02","pubTimestamp":1787716971,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Appoints Song Xiaomi As CFOAug 26 (Reuters)-Sihuan Pharmaceutical0460.HK:APPOINTS SONG XIAOMI AS CHIEF FINANCIAL OFFICER EFFECTIVE 26 AUGUST 2026MIAO GUILI RESIGNS AS EXECUTIVE DIRECTOR, DEPUTY CEO, AND CFO EFFECTIVE 26 AUGUST 2026Further company coverage:0460.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N002:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","BK1593","BK1191","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662641837","title":"Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662641837","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662641837?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:01","pubTimestamp":1787716878,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N002:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1515","BK1600","BK1191","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662764909","title":"Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662764909","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662764909?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:00","pubTimestamp":1787716853,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1593","BK1600","00460"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}